Table 1.
Patient characteristics
| Patients with e′ by TTE and MRI n = 59 | Patients with PC‐MRI n = 14 | Patients with PWCP and TTE n = 8 | Patients with LVEDP and TTE n = 6 | |
|---|---|---|---|---|
| Age (years) | 51 ± 17 | 58 ± 21 | 38 ± 17 | 65 ± 14 |
| Female (%) | 37% | 57% | 12% | 33% |
| BMI (kg/m2) | 28 ± 5 | 28 ± 6 | 29 ± 8 | 30 ± 7 |
| AF (%) | 29% | 29% | 12% | 17% |
| HCM (%) | 23% | 86% | 12% | 50% |
| Diabetes (%) | 4% | 0% | 12% | 0% |
| CAD (%) | 8% | 7% | 12% | 50% |
| Tx HTN (%) | 54% | 64% | 62% | 50% |
| LV‐EDV indexed (kg/m2) | 85 ± 26 | 68 ± 21 | 112 ± 45 | 91 ± 15 |
| LV‐EF (%) | 55 ± 12 | 66 ± 8 | 41 ± 18 | 55 ± 9 |
| LV mass, indexed (kg/m2) | 69 ± 30 | 96 ± 32 | 89 ± 38 | 87 ± 36 |
| LA‐vol min, indexed (mL/m2) | 24 ± 14 | 20 ± 9 | 24 ± 13 | 26 ± 8 |
| LA‐EF (%) | 48 ± 17 | 45 ± 20 | 43 ± 18 | 43 ± 10 |
| LA LGE (√%) | 8.7 ± 10 | 17 ± 15 | 8.0 ± 5.7 | 9.4 ± 14 |
Values are given as mean ± SD. Volumes and mass were indexed to body surface area.
TTE, transthoracic echocardiography; MRI, magnetic resonance imaging; PC, phase‐contrast; PCWP, pulmonary capillary wedge pressure; LVEDP, left ventricular end‐diastolic pressure; BMI, body mass index; AF, atrial fibrillation; HCM, hypertrophic cardiomyopathy; CAD, coronary artery disease; Tx HTN, Treatment of hypertension; LV‐EDV, left ventricular end‐diastolic volume; LV‐EF, left ventricular ejection fraction; LA‐vol min, minimum left atrial volume (atrial end‐systole); LA‐EF, left atrial ejection fraction; LA LGE, left atrial late gadolinium enhancement.